Hydroxychloroquine Use Is Associated with a Lower Risk of Major Adverse Cardiovascular Events in Medicare Recipients with Rheumatoid Arthritis

被引:0
|
作者
Iyer, Priyanka [1 ]
Gao, Yubo [2 ]
Girotra, Saket [2 ]
Curtis, Jeffrey [3 ]
Vaughan-Sarrazin, Mary [1 ]
Singh, Namrata [1 ]
机构
[1] Univ Iowa, Iowa City, IA USA
[2] Univ Iowa Hosp & Clin, Iowa City, IA 52242 USA
[3] Univ Alabama Birmingham, Birmingham, AL USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
1891
引用
收藏
页数:3
相关论文
共 50 条
  • [31] Thiazolidinedione treatment is not associated with an increased risk of major adverse cardiovascular events
    Bilik, Dorian
    McEwen, Laura N.
    Selby, Joe V.
    Marrero, David G.
    Brown, Arleen F.
    Herman, William H.
    DIABETES, 2008, 57 : A85 - A85
  • [32] Is incident stroke associated with increased risk of major adverse cardiovascular events?
    Johansen, Michelle C.
    Sheth, Kevin N.
    NEUROLOGY, 2020, 94 (15) : 644 - 645
  • [33] Risk of Major Adverse Cardiovascular Events in ANCA-associated Vasculitis
    Idoate, Jon
    Mourguet, Morgane
    Villeneuve, Thomas
    Prevot, Gregoire
    Guilleminault, Laurent
    David, Ribes
    Faguer, Stan
    Huart, Antoine
    Chauveau, Dominique
    Alric, Laurent
    Michaud, Martin
    Sailler, Laurent
    Chavez, Sebastien De Almeida
    Mouchon, Emmanuelle
    Lairez, Olivier
    Pugnet, Gregory
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 4725 - 4727
  • [34] Risk Factors for Major Adverse Cardiovascular Events and Malignancies in Patients with Rheumatoid Arthritis in a Real-World Setting in Japan
    Hirano, Toshitaka
    Sugiyama, Naonobu
    Hoshi, Masato
    Jo, Joo-Young
    Shin, Kichul
    Yamaoka, Kunihiro
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2526 - 2529
  • [35] RISK FACTORS FOR MAJOR ADVERSE CARDIOVASCULAR (CV) EVENTS (MACE) IN RHEUMATOID ARTHRITIS (RA) PATIENTS TREATED WITH TOCILIZUMAB (TCZ)
    Rao, V. U.
    Pavlov, A.
    Klearman, M.
    Musselman, D.
    Giles, J. T.
    Bathon, J. M.
    Sattar, N.
    Lee, J. S.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 356 - 357
  • [36] Hydroxychloroquine Use and Risk of CKD in Patients with Rheumatoid Arthritis
    Wu, Chia-Lin
    Chang, Chia-Chu
    Kor, Chew-Teng
    Yang, Tao-Hsiang
    Chiu, Ping-Fang
    Tarng, Der-Cherng
    Hsu, Chih-Cheng
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2018, 13 (05): : 702 - 709
  • [37] Association Between Lipid Levels and Major Adverse Cardiovascular Events in Rheumatoid Arthritis Compared to Non-Rheumatoid Arthritis Patients
    Liao, Katherine P.
    Liu, Jun
    Lu, Bing
    Solomon, Daniel H.
    Kim, Seoyoung C.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67 (08) : 2004 - 2010
  • [38] Major adverse cardiovascular events and mortality with opioids versus NSAIDs initiation in patients with rheumatoid arthritis
    Ozen, Gulsen
    Pedro, Sofia
    Michaud, Kaleb
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (11) : 1487 - 1494
  • [39] Major Adverse Cardiovascular Events and Mortality with Opioids versus NSAIDs Initiation in Patients with Rheumatoid Arthritis
    Ozen, Gulsen
    Pedro, Sofia
    Michaud, Kaleb
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 3274 - 3277
  • [40] Lower Risk of Major Cardiovascular Events Associated with Adherence to Colesevelam HCI
    Ye, Xin
    Qian, Chunlin
    Liu, Jiannong
    St Peter, Wendy L.
    PHARMACOTHERAPY, 2013, 33 (10): : 1062 - 1070